共 9 条
- [1] European Medicines Agency, GUID REP PHYS BAS PH
- [3] Establishing a Multidisciplinary Framework to Study Drug-Drug Interactions of Hormonal Contraceptives: An Invitation to Collaborate [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2018, 7 (11): : 706 - 708
- [4] Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2016, 5 (03): : 93 - 122
- [5] A Generic Integrated Physiologically based Whole-body Model of the Glucose-Insulin-Glucagon Regulatory System [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2013, 2 (08):
- [6] Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (04): : 221 - 225
- [7] Teorell T, 1937, ARCH INT PHARMACOD T, V57, P205
- [8] US Food and Drug Administration, PHYS BAS PHARM AN FO
- [9] Application of Physiologically Based Pharmacokinetic (PBPK) Modeling to Support Dose Selection: Report of an FDA Public Workshop on PBPK [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (04): : 226 - 230